Pulmonary Medicine
Scope & Guideline
Elevating Knowledge in Respiratory Research
Introduction
Aims and Scopes
- Respiratory Diseases and Conditions:
The journal publishes research on various respiratory diseases, including chronic obstructive pulmonary disease (COPD), asthma, pneumonia, pulmonary fibrosis, and lung cancer, exploring their etiology, progression, and management strategies. - Innovative Diagnostic Techniques:
Research on novel diagnostic approaches, including imaging techniques, biomarker identification, and advanced bronchoscopy methods, aiming to improve early detection and management of pulmonary conditions. - Therapeutic Advances:
Focus on studies evaluating new treatment modalities, including pharmacological interventions, immunotherapy, and surgical techniques, to enhance patient outcomes in lung disease management. - Public Health and Epidemiology:
The journal emphasizes research related to the epidemiology of respiratory diseases, health disparities, and the impact of environmental factors on lung health, contributing to public health knowledge. - Clinical Guidelines and Quality of Care:
Articles addressing the development and application of clinical guidelines, quality improvement initiatives, and healthcare policies aimed at optimizing care for patients with respiratory diseases.
Trending and Emerging
- Telemedicine and Remote Monitoring:
With the rise of digital health, there is an increasing focus on telemedicine and remote monitoring technologies that enhance patient management and follow-up care for chronic lung diseases. - Artificial Intelligence and Machine Learning:
The application of AI and machine learning in predicting outcomes, diagnosing diseases, and personalizing treatment plans is gaining traction, showcasing innovative approaches to enhance clinical decision-making. - Long COVID and Post-Acute Sequelae:
Research on the long-term effects of COVID-19, including post-acute sequelae, is rapidly emerging as a critical area of focus, addressing the need for understanding and managing ongoing respiratory issues after infection. - Epidemiology of Environmental Exposures:
Studies examining the impact of environmental factors, such as air pollution and occupational exposures, on respiratory health are becoming more prominent, highlighting the need for public health interventions. - Interdisciplinary Approaches to Pulmonary Care:
There is a growing trend towards interdisciplinary research that integrates pulmonology with other specialties, such as cardiology, infectious diseases, and rheumatology, to provide comprehensive care for complex patients.
Declining or Waning
- Traditional Pharmacotherapy:
There is a decreasing emphasis on studies solely focused on traditional pharmacological treatments for respiratory diseases, as the field shifts towards personalized medicine and combination therapies. - Basic Science Research:
Research primarily focused on basic molecular and cellular mechanisms of respiratory diseases is becoming less prominent, with a growing preference for translational studies that bridge laboratory findings to clinical applications. - Single-Center Studies:
The prevalence of single-center studies seems to be waning, replaced by multicenter collaborations that provide broader data and enhance the generalizability of findings. - Descriptive Epidemiological Studies:
There is a decline in the publication of purely descriptive epidemiological studies, as researchers increasingly focus on intervention studies and clinical trials that provide actionable insights. - Case Reports:
The frequency of case reports is decreasing, possibly due to a shift towards larger studies that can provide more comprehensive data and findings.
Similar Journals
RESPIRATORY MEDICINE
Elevating Research in Respiratory MedicineRespiratory Medicine is a leading journal in the field of pulmonary and respiratory medicine, dedicated to advancing knowledge and research from 1989 to 2024. Published by W B Saunders Co Ltd, this esteemed journal is recognized for its high impact, reflected in its Q1 quartile ranking in 2023 within the category of Pulmonary and Respiratory Medicine and its impressive Scopus ranking of 27 out of 155 journals, placing it in the 82nd percentile. With a focus on publishing groundbreaking research, comprehensive reviews, and innovative practices, Respiratory Medicine serves as an essential resource for health professionals, researchers, and students aiming to improve patient outcomes and understand complex respiratory conditions. While the journal is not Open Access, its contributions to the scientific community are invaluable, providing insights that drive both academic and clinical advancements in respiratory health.
Chronic Respiratory Disease
Advancing research for healthier lungs.Chronic Respiratory Disease is a leading peer-reviewed journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by SAGE Publications Ltd since its inception in 2004, this open-access journal has been at the forefront of disseminating high-quality research aimed at addressing chronic respiratory conditions. With an impressive impact factor and classified as Q1 in the 2023 category of Pulmonary and Respiratory Medicine, it ranks an admirable #45 out of 155 in Scopus, placing it in the 71st percentile of its field. This journal features a diverse range of studies, reviews, and clinical insights that cater to researchers, healthcare professionals, and students alike, encouraging the exchange of innovative ideas and practices in respiratory disease management. Operating out of London, UK, Chronic Respiratory Disease exemplifies a commitment to openness, having transitioned to open access since 2017, thereby ensuring that pivotal research is readily accessible to a global audience engaged in the improvement of respiratory health.
EUROPEAN RESPIRATORY JOURNAL
Transforming Respiratory Health Through ScienceThe EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.
Indian Journal of Respiratory Care
Championing Research for a Breath of Fresh AirWelcome to the Indian Journal of Respiratory Care, a premier platform dedicated to advancing research and clinical practices in the field of respiratory health. Published by JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD, this journal has established itself as a crucial resource for researchers, healthcare professionals, and educators since embracing an Open Access model in 2012, ensuring maximum visibility and accessibility of vital research findings. The journal aims to disseminate high-quality articles encompassing a wide range of topics, including but not limited to, respiratory diseases, pulmonary care, and innovative treatment approaches. With its commitment to fostering collaboration and knowledge exchange, the Indian Journal of Respiratory Care is poised to make a significant impact in the ever-evolving landscape of respiratory medicine. As the field continues to grow, this journal serves as an essential touchpoint for those invested in enhancing patient care and outcomes.
THORAX
Illuminating the path in pulmonary and respiratory studies.THORAX is a premier academic journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine. Published by the esteemed BMJ Publishing Group in the United Kingdom, this journal has been a pivotal resource for researchers and clinicians since its inception in 1946. With a remarkable ranking of #6 out of 155 in its category, THORAX holds a prestigious position within the top 4% of its field, as indicated by its 2023 Q1 quartile classification and a strong Scopus ranking. The journal focuses on publishing high-quality research, reviews, and clinical studies that are essential for understanding respiratory diseases and their management. Although it is not an open-access journal, THORAX provides vital contributions to the academic community, fostering dialogue and innovation in pulmonary medicine. As it approaches its converged years, concluding in 2024, researchers, professionals, and students are encouraged to explore its rich repository of knowledge, while engaging with the most current advancements in the field.
Canadian Journal of Respiratory Critical Care and Sleep Medicine
Transforming critical care through rigorous research.Welcome to the Canadian Journal of Respiratory Critical Care and Sleep Medicine, a prestigious peer-reviewed journal published by Taylor & Francis Inc. With an ISSN of 2474-5332 and an E-ISSN of 2474-5340, this journal serves as a vital platform for disseminating cutting-edge research in the fields of critical care, intensive care medicine, and pulmonary and respiratory medicine. Since its inception in 2017, the journal has established itself within the academic community, currently holding a Q2 ranking in Critical Care and Intensive Care Medicine and a Q3 ranking in Pulmonary and Respiratory Medicine for 2023. Although it operates under a standard access model, the journal remains committed to providing valuable insights and advancing knowledge through rigorous research articles, reviews, and case studies. Positioned in the heart of the United States, the journal aims to foster collaboration and innovation among healthcare professionals, researchers, and students dedicated to enhancing respiratory care and critical treatment protocols. Join us in exploring the dynamic intersection of research and practice that defines our mission.
Egyptian Journal of Chest Diseases and Tuberculosis
Bridging clinical practice and innovative research in pulmonary medicine.The Egyptian Journal of Chest Diseases and Tuberculosis is a premier Open Access journal published by Wolters Kluwer Medknow Publications, focusing on the latest advancements in the fields of respiratory diseases, pulmonary medicine, and tuberculosis management. With an ISSN of 0422-7638 and an E-ISSN of 2090-9950, this journal aims to disseminate high-quality research, reviews, and clinical insights that advance the understanding and treatment of chest diseases. Since its transition to Open Access in 2018, the journal has garnered increased visibility, enabling researchers across the globe to contribute and access valuable content without barriers. Situated in India, the journal is dedicated to bridging the gap between clinical practice and research, emphasizing the significance of innovative therapeutic strategies and public health approaches in combating respiratory illnesses. We invite researchers, healthcare professionals, and students to engage with our publications as we continue to foster knowledge and foster collaboration within the global medical community.
LUNG
Connecting researchers and clinicians in the fight against lung diseases.LUNG is a prestigious academic journal that has been a cornerstone in the field of Pulmonary and Respiratory Medicine since its inception in 1959. Published by SPRINGER, the journal holds an impressive Q1 ranking in its category for 2023, reflecting its commitment to disseminating high-quality research and advancing clinical practices in respiratory health. With a Scopus rank of 24 out of 155 in its field, representing the top 16% of journals, LUNG continues to serve as a vital platform for researchers, clinicians, and students who are dedicated to addressing the complexities of lung diseases. Although currently not an open-access journal, LUNG offers valuable insights and significant contributions to the understanding of respiratory conditions, ensuring that its readership stays at the forefront of medical advancements. Researchers and professionals are encouraged to submit their work and engage with a thriving academic community that is passionate about improving patient outcomes in pulmonary health.
Egyptian Journal of Bronchology
Transforming insights into action for better respiratory care.Egyptian Journal of Bronchology, published by SPRINGER, is a premier open access journal dedicated to advancing the field of respiratory medicine, particularly focusing on bronchial diseases and disorders. Since its establishment in 2013, this journal has provided a platform for the dissemination of high-quality research articles, systematic reviews, and clinical studies, making significant contributions to the understanding and management of bronchological conditions. With its commitment to open access, the journal ensures that research findings are readily available to a global audience, fostering knowledge exchange among researchers, healthcare professionals, and students alike. The Egyptian Journal of Bronchology serves as an essential resource in the field, reflecting a growing emphasis on accessible scientific knowledge and collaborative research in respiratory health.
RESPIROLOGY
Transforming Knowledge into Respiratory SolutionsRESPIROLOGY is a prestigious academic journal that focuses on the field of Pulmonary and Respiratory Medicine, publishing high-quality research and comprehensive reviews that contribute significantly to the understanding and management of respiratory health. As a distinguished publication of WILEY, it has established a strong presence in the academic world with an impressive impact factor and ranked in the Q1 category, recognized for its influence and innovation in the field. RESPIROLOGY is committed to disseminating cutting-edge research from 1996 through 2024, appearing regularly in SCOPUS with a rank of #14 out of 155, placing it in the rarefied 91st percentile among its peers. The journal invites contributions from researchers, professionals, and students, fostering a collaborative space for advancing knowledge in pulmonary medicine. Although it does not offer open access, its readership spans globally, indicating the high regard in which it is held within the scientific community.